Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.

Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.

Malinda and David Morrison III welcomed their son in 2022 after years of trying to conceive

Anthony Rosenzweig's lab is awarded one of three national AHA Center grants

Buprenorphine prescribing for opioid addiction used to require a special waiver from the federal government, but a new study shows what happened in the first year after that requirement was lifted.

Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.

Anthony Rosenzweig, M.D., has paper come out on the cover of Science Translational Medicine

Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.

Paul Picton, M.B., Ch.B., MRCP, FRCA, has been appointed interim chair of the Department of Anesthesiology in the Medical School, effective May 1. The provost has provided interim approval of his appointment, and it will be reported at the May Board of Regents meeting

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

The number of patients using cannabis for medical purposes has increased more than 600 percent since 2016.

Anita Valanju Shelgikar (she/her/hers), MD, MHPE, is a professor of neurology at the University of Michigan Medical School and the director of the sleep medicine fellowship at Michigan Medicine.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.